Literature DB >> 11026579

Ultrasonographic tissue characterization in monitoring tumor response to neoadjuvant chemotherapy in locally advanced breast cancer (work in progress).

S Huber1, M Medl, M Vesely, H Czembirek, I Zuna, S Delorme.   

Abstract

A program of computer-assisted texture analysis was applied to evaluate its usefulness for objective description of changes in tumor architecture due to primary medical treatment in patients with locally advanced breast cancer. Changes in values of parameters of the statistical pattern recognition technique were compared to ultrasonographically depictable, subjectively recorded changes in echogenicity and echotexture (brightness, homogeneity) and reviewed with regard to histopathologic evaluation of tumor regression. Characteristic trends of defined quantitative texture parameters (mean gradient, mean gray value, contrast from the co-occurrence matrix) corresponded to visually depictable changes of the B-mode image and underlying histopathologic changes. The results indicate that quantitative texture analysis may aid in noninvasive monitoring of tumor response to neoadjuvant chemotherapy.

Entities:  

Mesh:

Year:  2000        PMID: 11026579     DOI: 10.7863/jum.2000.19.10.677

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  6 in total

1.  Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer.

Authors:  Jason D Keune; Donna B Jeffe; Mario Schootman; Abigail Hoffman; William E Gillanders; Rebecca L Aft
Journal:  Am J Surg       Date:  2010-04       Impact factor: 2.565

Review 2.  Imaging Considerations and Interprofessional Opportunities in the Care of Breast Cancer Patients in the Neoadjuvant Setting.

Authors:  Anna G Sorace; Sara Harvey; Anum Syed; Thomas E Yankeelov
Journal:  Semin Oncol Nurs       Date:  2017-09-15       Impact factor: 2.315

3.  Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment.

Authors:  Shudong Jiang; Brian W Pogue; Peter A Kaufman; Jiang Gui; Michael Jermyn; Tracy E Frazee; Steven P Poplack; Roberta DiFlorio-Alexander; Wendy A Wells; Keith D Paulsen
Journal:  Clin Cancer Res       Date:  2014-10-07       Impact factor: 12.531

4.  Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes.

Authors:  Shudong Jiang; Brian W Pogue; Colin M Carpenter; Steven P Poplack; Wendy A Wells; Christine A Kogel; Jorge A Forero; Lori S Muffly; Gary N Schwartz; Keith D Paulsen; Peter A Kaufman
Journal:  Radiology       Date:  2009-06-09       Impact factor: 11.105

5.  Which imaging modality is superior for prediction of response to neoadjuvant chemotherapy in patients with triple negative breast cancer?

Authors:  Jordan J Atkins; Catherine M Appleton; Carla S Fisher; Feng Gao; Julie A Margenthaler
Journal:  J Oncol       Date:  2013-02-11       Impact factor: 4.375

6.  Neo-adjuvant capecitabine chemotherapy in women with newly diagnosed locally advanced breast cancer in a resource-poor setting (Nigeria): efficacy and safety in a phase II feasibility study.

Authors:  Olukayode A Arowolo; Uchenna O Njiaju; Temidayo O Ogundiran; Oyewale Abidoye; Olukayode O Lawal; Millicent Obajimi; Adebayo V Adetiloye; Hae K Im; Akinbolaji A Akinkuolie; Abideen Oluwasola; Kayode Adelusola; Adesunkanmi A Kayode; Augustine E Agbakwuru; Helen Oduntan; Chinedum P Babalola; Gini Fleming; Olusola C Olopade; Adeyinka Gladys Falusi; Muheez A Durosinmi; Olufunmilayo I Olopade
Journal:  Breast J       Date:  2013-07-19       Impact factor: 2.431

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.